Result of AGM

RNS Number : 2782Z
Alliance Pharma PLC
25 May 2016
 

For immediate release

25 May 2016

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

 

Result of AGM

 

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, announces that all resolutions put to shareholders at today's Annual General Meeting were duly passed.

 

 

For further information:

 

Alliance Pharma plc

+ 44 (0) 1249 466966

 

John Dawson, Chief Executive

Andrew Franklin, Chief Financial Officer

 

 

Sarah Robinson, Company Secretary

 

 

www.alliancepharma.co.uk

 

 

 

Buchanan

+ 44 (0) 20 7466 5000

 

Mark Court / Sophie Cowles / Jane Glover

 

 

 

 

 

Numis Securities Limited

+ 44 (0) 20 7260 1000

 

Nominated Adviser: Michael Meade / Freddie Barnfield

 

Corporate Broking: James Black / Toby Adcock

 

 

       

 

Notes to editors:

 

About Alliance Pharma

Alliance, founded in 1998, is an international specialty pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors.  Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGAKPDDKBKDDPB
UK 100